Andrea S Gershon1,2,3,4,5, Laura C Maclagan2, Jin Luo2, Teresa To2,6,5, Tetyana Kendzerska7,8,9, Matthew B Stanbrook2,3,4,10, Jean Bourbeau11, Jacob Etches2, Shawn D Aaron7,8. 1. 1 Department of Medicine and Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 2. 2 Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. 3. 3 Department of Medicine. 4. 5 Institute of Health Policy, Management, and Evaluation, and. 5. 4 The Hospital for Sick Children, Research Institute, Toronto, Ontario, Canada. 6. 6 Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 7. 7 The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. 8. 8 Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. 9. 9 Institute for Clinical Evaluative Sciences, Ottawa, Ontario, Canada. 10. 10 University Health Network, Toronto, Ontario, Canada; and. 11. 11 McGill University Health Centre, Montreal, Quebec, Canada.
Abstract
RATIONALE: The burden of advanced chronic obstructive pulmonary disease (COPD) is high globally; however, little is known about how often end-of-life strategies are used by this population. OBJECTIVES: To describe trends in the use of end-of-life care strategies by people with advanced COPD in Ontario, Canada. METHODS: A population-based repeated cross-sectional study examining end-of-life care strategies in individuals with advanced COPD was conducted. Annual proportions of individuals who received formal palliative care, long-term oxygen therapy, or opioids from 2004 to 2014 were determined. Results were age and sex standardized and stratified by age, sex, socioeconomic status, urban/rural residence, and immigrant status. Measurement/Main Results: There were 151,912 persons with advanced COPD in Ontario between 2004 and 2014. Use of formal palliative care services increased 1% per year from 5.3% in 2004 to 14.3% in 2014 (P value for trend < 0.001), whereas use of long-term oxygen therapy increased 1.1% per year from 26.4% in 2004 to 35.3% in 2013 (P value for trend < 0.001). The use of opioids was relatively stable (40.0% in 2004 and 41.8% in 2014; P value for trend = 0.08). Younger individuals were less likely to use formal palliative care services and long-term oxygen therapy. Males were less likely than females to receive long-term oxygen therapy and opioids. CONCLUSIONS: The proportion of people with advanced COPD using end-of-life strategies, although increasing, remains low. Efforts should focus on increasing access to such strategies and educating patients and providers of their benefits.
RATIONALE: The burden of advanced chronic obstructive pulmonary disease (COPD) is high globally; however, little is known about how often end-of-life strategies are used by this population. OBJECTIVES: To describe trends in the use of end-of-life care strategies by people with advanced COPD in Ontario, Canada. METHODS: A population-based repeated cross-sectional study examining end-of-life care strategies in individuals with advanced COPD was conducted. Annual proportions of individuals who received formal palliative care, long-term oxygen therapy, or opioids from 2004 to 2014 were determined. Results were age and sex standardized and stratified by age, sex, socioeconomic status, urban/rural residence, and immigrant status. Measurement/Main Results: There were 151,912 persons with advanced COPD in Ontario between 2004 and 2014. Use of formal palliative care services increased 1% per year from 5.3% in 2004 to 14.3% in 2014 (P value for trend < 0.001), whereas use of long-term oxygen therapy increased 1.1% per year from 26.4% in 2004 to 35.3% in 2013 (P value for trend < 0.001). The use of opioids was relatively stable (40.0% in 2004 and 41.8% in 2014; P value for trend = 0.08). Younger individuals were less likely to use formal palliative care services and long-term oxygen therapy. Males were less likely than females to receive long-term oxygen therapy and opioids. CONCLUSIONS: The proportion of people with advanced COPD using end-of-life strategies, although increasing, remains low. Efforts should focus on increasing access to such strategies and educating patients and providers of their benefits.
Entities:
Keywords:
chronic obstructive pulmonary disease; health services; terminal care
Authors: Wassim W Labaki; Lucas M Kimmig; Gökhan M Mutlu; MeiLan K Han; Surya P Bhatt Journal: Am J Respir Crit Care Med Date: 2019-06-15 Impact factor: 21.405
Authors: Anand S Iyer; J Nicholas Dionne-Odom; Stephanie M Ford; Sheri L Crump Tims; Elizabeth D Sockwell; Nataliya V Ivankova; Cynthia J Brown; Rodney O Tucker; Mark T Dransfield; Marie A Bakitas Journal: Ann Am Thorac Soc Date: 2019-08
Authors: Yumeng Wen; Changchuan Jiang; Holly M Koncicki; Carol R Horowitz; Richard S Cooper; Aparna Saha; Steven G Coca; Girish N Nadkarni; Lili Chan Journal: J Am Soc Nephrol Date: 2019-08-06 Impact factor: 10.121
Authors: Kieran L Quinn; Therese Stukel; Nathan M Stall; Anjie Huang; Sarina Isenberg; Peter Tanuseputro; Russell Goldman; Peter Cram; Dio Kavalieratos; Allan S Detsky; Chaim M Bell Journal: BMJ Date: 2020-07-06
Authors: Kieran L Quinn; Amy T Hsu; Glenys Smith; Nathan Stall; Allan S Detsky; Dio Kavalieratos; Douglas S Lee; Chaim M Bell; Peter Tanuseputro Journal: J Am Heart Assoc Date: 2020-02-19 Impact factor: 5.501
Authors: Tetyana Kendzerska; Jason W Nickerson; Amy T Hsu; Andrea S Gershon; Robert Talarico; Sunita Mulpuru; Smita Pakhale; Peter Tanuseputro Journal: Int J Chron Obstruct Pulmon Dis Date: 2019-07-31